Dr. Ganesh Raghu is a world-renowned pulmonary specialist and international authority on interstitial lung diseases at the University of Washington. He currently serves as Director of the Center for Interstitial Lung Diseases and Director of the WASOG Center for Excellence for Sarcoidosis while also co-directing the Scleroderma Clinic at UW Medical Center. After earning his medical degree from Mysore Medical College in 1967, he completed postdoctoral training in the United Kingdom and residency at the State University of New York at Buffalo before specializing in pulmonary medicine through fellowships at the University of Washington. Dr. Raghu founded the UW Lung Transplant Program and has maintained leadership roles in pulmonary research and clinical care for over three decades.
Dr. Raghu's pioneering research has fundamentally transformed the understanding and management of idiopathic pulmonary fibrosis and related interstitial lung disorders through his extensive work spanning basic science, translational research, and clinical trials. He chairs international committees that develop evidence-based guidelines for the diagnosis and management of IPF and hypersensitivity pneumonitis while having co-chaired committees establishing clinical practice standards for bronchoalveolar lavage in ILD management. His thirty-five plus years of research have significantly advanced the field through prospective clinical studies on pulmonary fibrosis associated with scleroderma and sarcoidosis, helping to provoke interest in novel treatment strategies based on disease pathogenesis. This work has established him as a highly influential figure in pulmonary medicine with recognition as a Highly Cited Researcher by Clarivate Web of Science from 2019 to 2022.
Beyond his research accomplishments, Dr. Raghu plays a pivotal role in shaping the global landscape of interstitial lung disease through his leadership in the NIH-funded IPFnet clinical research network and numerous pharmaceutical industry-sponsored clinical trials. He has served as an ad hoc member of the NIH lung biology and pathology study section, contributing his expertise to national research priorities and funding decisions. Recognized consistently as one of Seattle's Best Doctors since 2001 and featured in Who's Who in America for over two decades, Dr. Raghu continues to advance the field through his commitment to evidence-based medicine and patient-centered care. His ongoing work focuses on refining diagnostic approaches and developing innovative therapeutic strategies for complex pulmonary disorders, ensuring his enduring impact on both clinical practice and research methodology in pulmonary medicine.
